CVS Health outlines plan to split into two independent publicly traded companies

By Public Technologies
  • CVS Health plans to separate into two independent, publicly traded companies, CVS Health and CVS Pharmacy, in the first half of 2028.
  • The separation is intended to be tax-free for U.S. federal income tax purposes; shareholders will hold shares in both companies.
  • Estimated 2026 revenue is approximately $320 billion for CVS Health, compared with $145 billion for CVS Pharmacy.
  • David Joyner will become CVS Health chairman and CEO; Prem Shah will lead CVS Pharmacy as CEO.
  • Both companies expect investment-grade credit ratings at separation, with strong free cash flow supporting investment priorities and attractive dividends.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. CVS Health Corporation published the original content used to generate this news brief on November 04, 2026, and is solely responsible for the information contained therein.

Capital.com is an execution-only brokerage platform and the content provided on the Capital.com website is intended for informational purposes only and should not be regarded as an offer to sell or a solicitation of an offer to buy the products or securities to which it applies. No representation or warranty is given as to the accuracy or completeness of the information provided.

The information provided does not constitute investment advice nor take into account the individual financial circumstances or objectives of any investor. Any information that may be provided relating to past performance is not a reliable indicator of future results or performance.

To the extent permitted by law, in no event shall Capital.com (or any affiliate or employee) have any liability for any loss arising from the use of the information provided. Any person acting on the information does so entirely at their own risk.

Any information which could be construed as “investment research” has not been prepared in accordance with legal requirements designed to promote the independence of investment research and as such is considered to be a marketing communication.